Application Form for Marketing Authorisation (Registration) of Medicines Updated | 5 | 20 January 2025 | Product Registration |  |  |
Related Product Registration Application Form | 1 | 19 April 2021 | Product Registration |  |  |
Model Cover Letter New | 1 | 20 January 2025 | Product Registration |  |  |
Application Form for Renewal of Authorisation of Medicine New | 1 | 16 January 2025 | Product Registration | 
|  |
Model application Cover Letter for the Renewal of Marketing Authorisation of Medicine New | 1 | 16 January 2025 | Product Registration |  |  |
Content of the Annual Product Quality Review Report New | 1 | 16 January 2025 | Product Registration |  |  |
Application Form for Variation New | 1 | 30 January 2025 | Variation |  |  |
Application Form For Licensing as Importer of Medicines and Related Products | 3 | 10 July 2020 | Licensing |  |  |
Application Form for Licensing of Storage Facilities for Medicines and Related Products | 1 | 10 July 2020 | Licensing |  |  |
Application Form for Application for License for Repackaging of Medicines | 2 | 10 July 2020 | Licensing |  |  |
Application Form for Advertisement | 1 | 20 June 2020 | Advertising |  |  |
Clearance Permit Form for Donations | 1 | 19 May 2021 | Donations |  |  |
Checklist for Medicines and Related Products Donations | 1 | 19 May 2021 | Donations |  |  |
Import Clearance Permit Form | 5 | 19 April 2021 | Importation |  |  |
Medicines and Related Products Listing Form New | 3 | 14 November 2024 | Importation | N/A |  |
Medical Devices Listing Form New | 3 | 14 November 2024 | Importation | N/A |  |
Application Form for Import/ Export of
Controlled Medicines | 1 | 11 May 2022 | Importation/Exportation |  |  |
Export Permit Form For Medicines and Related Products | 2 | 10 July 2020 | Exportation |  |  |
Recall Information Form | 2 | 01 July 2020 | Recall |  |  |
Recall Report Form | 2 | 01 July 2020 | Recall |  |  |
Reporting Form for Suspected Adverse Drug Reactions | 2 | 10 December 2021 | Pharmacovigilance |  |  |
Adverse Event Following Immunization Reporting Form | 1 | 10 December 2021 | Pharmacovigilance |  |  |
Clinical Trial Application Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Declaration and Workload of Principal Investigator Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Curriculum Vitae For Key Personnel Conducting Clinical Trials Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Declaration of Sufficient Funds Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Import Application Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Clinical Trial Progress Report Form Updated | 2 | 26 February 2025 | Clinical Trials |  |  |
Clinical Trial Amendment Form | 2 | 28 April 2021 | Clinical Trials |  |  |
Serious Adverse Event (SAE) Report Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Final Clinical Trial Report Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Declaration of Investigator Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Non-Interventional Study Application Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Non-Interventional Study Report Form | 1 | 30 October 2020 | Clinical Trials |  |  |
Sponsor Indemnification For Sites and Investigators | 1 | 30 October 2020 | Clinical Trials |  |  |
Notification of the End of a Clinical Trial New | 1 | 26 February 2025 | Clinical Trials |  |  |
Request for Consideration for an EUA (Annex I) | 1 | 30 March 2022 | EUA |  |  |
Annex 1 of the Guideline for Emergency Use Authorisation of Medicines
including Vaccines and In-vitro Diagnostics: Pre-Submission Meeting Request Form New | 1 | 31 January 2025 | EUA |  |  |
Annex 5a of the Guideline for Emergency Use Authorisation of Medicines
including Vaccines and In-vitro Diagnostics: Healthcare Provider or Authorised Dispenser Information Template New | 1 | 31 January 2025 | EUA |  |  |
Annex 5b of the Guideline for Emergency Use Authorisation of Medicines
including Vaccines and In-vitro Diagnostics: Recipients Information Template New | 1 | 31 January 2025 | EUA |  |  |
Manufacturer’s request for reference institution’s (RI) permission for sharing
RI-owned non- public information with MCA (Annex III) | 1 | 24 January 2022 | Reliance |  |  |
Quality Information Summary Of The Finished Pharmaceutical Product Approved By The Reference Institution (RI) (QIS-RI-FPP(crp)) (Annex IV a) | 1 | 24 January 2022 | Reliance |  |  |
Quality Information Summary (QIS) of the Biotherapeutic Product Approved by a Reference Institution (RI) (QIS-RI-BTP) (Annex IV b) | 1 | 24 January 2022 | Reliance |  |  |